SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/C9FA25E5D9F842706A9875CD5533D2159DE3375D1BF6D82A5EC64D2343DBC78455D8277625EB34B4951FDFF70A005F99>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/C9FA25E5D9F842706A9875CD5533D2159DE3375D1BF6D82A5EC64D2343DBC78455D8277625EB34B4951FDFF70A005F99
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/C9FA25E5D9F842706A9875CD5533D2159DE3375D1BF6D82A5EC64D2343DBC78455D8277625EB34B4951FDFF70A005F99
http://www.w3.org/2000/01/rdf-schema#comment
"Vav-1 expression may be associated with activated B-cell DLBCL origin and higher proliferative activity and indicate Vav-1 as a potential marker to identify tumours likely to respond to CD40-targeted therapies."
xsd:string
http://purl.uniprot.org/uniprot/#_E0452537E6692877715BE0279A1F80BD8224458BF200D561555525ED7B8277D003A36F0D444350BAC2A0ACA88714B194
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/C9FA25E5D9F842706A9875CD5533D2159DE3375D1BF6D82A5EC64D2343DBC78455D8277625EB34B4951FDFF70A005F99
http://purl.uniprot.org/uniprot/Q96D37
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/C9FA25E5D9F842706A9875CD5533D2159DE3375D1BF6D82A5EC64D2343DBC78455D8277625EB34B4951FDFF70A005F99
http://purl.uniprot.org/uniprot/#_Q96D37-mappedCitation-20155735
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/C9FA25E5D9F842706A9875CD5533D2159DE3375D1BF6D82A5EC64D2343DBC78455D8277625EB34B4951FDFF70A005F99